Advocacy intelligence hub — real-time data for patient organizations
Cogent Biosciences, Inc. — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Foundation grants
Foundation Grants1
HealthWell Foundation — Systemic mastocytosis
HealthWell Foundation
Patient Assistance Programs1
Ayvakit
Blueprint Medicines Corporation
Ayvakit
(avapritinib)Orphan drugstandardBlueprint Medicines Corporation
Kinase Inhibitor [EPC]
12.1 Mechanism of Action Avapritinib is a tyrosine kinase inhibitor that targets KIT D816V, PDGFRA and PDGFRA D842 mutants as well as multiple KIT exo...
Cimetidine
(CIMETIDINE)Orphan drugstandardChartwell RX, LLC
Histamine-2 Receptor Antagonist [EPC]
Olivier Hermine, MD
Assistance Publique - Hôpitaux de Paris
Joseph H Butterfield, MD, M.D
Mayo Clinic
📍 ROCHESTER, MN
Laurent FRENZEL, MD
Assistance Publique - Hôpitaux de Paris
Srdan Verstovsek, MD, M.D., PhD
M.D. Anderson Cancer Center
📍 HOUSTON, TX
David Maloney
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Olivier Lortholary, MD, PhD
Hôpital Necker, Paris, France